- 专利标题： HETEROCYCLIC COMPOUND
-
申请号： US17226854申请日： 2021-04-09
-
公开(公告)号： US20210340114A1公开(公告)日： 2021-11-04
- 发明人: Yoshihiro Banno , Masahiro Kamaura , Kazuaki Takami , Koichiro Fukuda , Shigekazu Sasaki
- 申请人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 申请人地址： JP Osaka
- 专利权人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人地址： JP Osaka
- 优先权： JP2014-217770 20141024
- 主分类号： C07D263/46
- IPC分类号： C07D263/46 ; A61K31/4418 ; A61P27/02 ; A61K31/421 ; C07D231/22 ; C07D239/34 ; A61K31/505 ; C07D263/38 ; C07D213/70 ; C07D213/65 ; C07D231/12 ; A61K31/415 ; C07K14/47 ; C12N15/09
摘要：
Provided is a heterocyclic compound having a superior RBP4-lowering action and useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.
A compound represented by the formula (I): wherein each symbol is as defined in the Description, or a salt thereof has a superior RBP4-lowering action, and is useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.
A compound represented by the formula (I): wherein each symbol is as defined in the Description, or a salt thereof has a superior RBP4-lowering action, and is useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.